EcoDrugPlus

Janus Kinase 1

Ensembl ID : ENSCMIG00000015076
Gene Symbol: JAK1
3 Cross references
240 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSCMIG00000017879
Gene Symbol: JAK2
3 Cross references
265 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCMIG00000012689
Gene Symbol: KIT
2 Cross references
211 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSCMIG00000014697
Gene Symbol: KRAS
4 Cross references
199 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCMIG00000016206
Gene Symbol: LYN
4 Cross references
197 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSCMIG00000007695
Gene Symbol: MALT1
2 Cross references
197 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSCMIG00000002896
Gene Symbol: MAPKAPK2
3 Cross references
242 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSCMIG00000016329
Gene Symbol: MAPKAPK5
4 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSCMIG00000003371
Gene Symbol: MKNK2
4 Cross references
226 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSCMIG00000019496
Gene Symbol: MDM2
3 Cross references
285 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCMIG00000009867
Gene Symbol: MET
4 Cross references
207 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSCMIG00000005765
Gene Symbol: MLST8
4 Cross references
196 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).